282 research outputs found
Tenascin C is a valuable marker for melanoma progression independent of mutational status and MAPK inhibitor therapy
Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic humaneratinocytes
Elevated expression of type IV collagenases (MMP-2 and MMP-9) has been strongly correlated with tumour progression and metastasis in various tumours. Here, we analysed expression and activation of these MMPs in non-tumourigenic HaCaT cells and the malignant HaCaT variant II-4 rt. In monolayer cultures, both cell types secreted latent MMP-2 (proMMP-2) in comparable amounts, while MMP-9 production was clearly higher in II-4 rt cells. Upon contact with fibrillar collagen type I the malignant II-4 rt cells, but not the HaCaT cells, gained the capability to activate proMMP-2. This process is shown to be membrane-associated and mediated by MT1-MMP. Surprisingly, all membrane preparations from either HaCaT cells or II-4 rt cells grown as monolayers, as well as within collagen gels, contained considerable amounts of active MT1-MMP. However, within collagen gels HaCaT cells showed significantly higher TIMP-2 levels compared to II-4 rt cells. This indicates that TIMP-2 might play a central role for MT1-MMP-mediated gelatinolytic activity. Indeed, collagen type I-induced MT1-MMP-mediated proMMP-2 activation by II-4 rt membranes could be completely abolished by an excess of TIMP-2. In conclusion, our data suggest that MT1-MMP-mediated proMMP-2 activation might be associated with malignant progression of epidermal tumour cells. © 2000 Cancer Research Campaig
Induction of Inflammatory Cytokines by a Keratin Mutation and their Repression by a Small Molecule in a Mouse Model for EBS
Epidermolysis bullosa simplex (EBS) is a skin disorder caused by mutations in keratin (K) 5 or K14 genes. It is widely regarded as a mechanobullous disease, resulting from a weakened cytoskeleton, causing extensive cytolysis. It was postulated by others that certain K14 mutations induce tumor necrosis factor-α (TNF-α) and increase apoptosis. Here, we report that in K5−/− mice and in a cell culture model of EBS, the mRNA and protein levels of TNF-α remain unaltered. Transcriptome analysis of K5−/− mice revealed, however, that the proinflammatory cytokines IL-6 and IL-1β were significantly upregulated at the mRNA level in K5−/− mouse skin. These results were confirmed by TaqMan real-time PCR and ELISA assays. We hypothesize that keratin mutations contribute to EBS in a mouse model by inducing local inflammation that mediates a stress response. Following clinical reports, we applied the small molecule doxycycline to K5−/− mice. We demonstrate that doxycycline extended the survival of neonatal K5−/− mice from less than 1 to up to 8hours. Microarray and TaqMan real-time PCR showed a downregulation of matrix metalloproteinase 13 and IL-1β, indicating an effect of doxycycline on transcription. Our data offer a novel small molecule-based therapy approach for EBS
In vivo imaging of extracellular matrix remodeling by tumor-associated fibroblasts.
Here we integrated multiphoton laser scanning microscopy and the registration of second harmonic generation images of collagen fibers to overcome difficulties in tracking stromal cell-matrix interactions for several days in live mice. We show that the matrix-modifying hormone relaxin increased tumor-associated fibroblast (TAF) interaction with collagen fibers by stimulating beta1-integrin activity, which is necessary for fiber remodeling by matrix metalloproteinases
Gene Expression Profiling Reveals Cross-talk between Melanoma and Fibroblasts: Implications for Host-Tumor Interactions in Metastasis
Fatty acid binding proteins (FABPs) in prostate, bladder and kidney cancer cell lines and the use of IL-FABP as survival predictor in patients with renal cell carcinoma
Interactions between microenvironment and cancer cells in two animal models of bone metastasis
The preferential proliferation of cancer cells in the bone microenvironment is poorly characterised. Expression pattern of bone marrow and other organ microenvironment in contact with osteolytic (Walker W256) and osteoblastic (MatLyLu MLL) metastases were investigated. Fisher and Copenhagen rats received, respectively, W256 and MLL cells injection. Bone and soft tissues were analysed by immunochemistry for DKK1, cathepsin K, RANKL, MCSF or IL6 expression. Tartrate-resistant acid phosphatase (TRAcP)-positive cells were detected by a histoenzymatic technique. In bone, expressions of MCSF and DKK1 were shown in stromal cells of the bone marrow, in contact with metastatic foci of both tumours. Many stromal cells were found RANKL positive in the vicinity of the tumours. Cells expressing cathepsin K and multinucleated TRAcP+ cells were found in direct contact with trabeculae but also in bone marrow spaces near metastatic cells. In extraosseous tumours, cells in contact with malignant cells did not expressed DKK1, MCSF, cathepsin K and IL6. Some RANKL+ cells were found in the periphery of subcutaneous tumours but may represent Langerhans cells. Abnormal presence of TRAcP+ cells was never observed in the vicinity of malignant cells. Interaction between stromal and cancer cells induces the expression on the formers of characteristics leading to osteoclastogenesis only in the bone microenvironment
Snake Venom Disintegrins and Cell Migration
Cell migration is a key process for the defense of pluricellular organisms against pathogens, and it involves a set of surface receptors acting in an ordered fashion to contribute directionality to the movement. Among these receptors are the integrins, which connect the cell cytoskeleton to the extracellular matrix components, thus playing a central role in cell migration. Integrin clustering at focal adhesions drives actin polymerization along the cell leading edge, resulting in polarity of cell movement. Therefore, small integrin-binding proteins such as the snake venom disintegrins that inhibit integrin-mediated cell adhesion are expected to inhibit cell migration. Here we review the current knowledge on disintegrin and disintegrin-like protein effects on cell migration and their potential use as pharmacological tools in anti-inflammatory therapy as well as in inhibition of metastatic invasion
Cell-scale degradation of peritumoural extracellular matrix fibre network and its role within tissue-scale cancer invasion
Local cancer invasion of tissue is a complex, multiscale process which plays
an essential role in tumour progression. Occurring over many different temporal
and spatial scales, the first stage of invasion is the secretion of matrix
degrading enzymes (MDEs) by the cancer cells that consequently degrade the
surrounding extracellular matrix (ECM). This process is vital for creating
space in which the cancer cells can progress and it is driven by the activities
of specific matrix metalloproteinases (MMPs). In this paper, we consider the
key role of two MMPs by developing further the novel two-part multiscale model
introduced in [33] to better relate at micro-scale the two micro-scale
activities that were considered there, namely, the micro-dynamics concerning
the continuous rearrangement of the naturally oriented ECM fibres within the
bulk of the tumour and MDEs proteolytic micro-dynamics that take place in an
appropriate cell-scale neighbourhood of the tumour boundary. Focussing
primarily on the activities of the membrane-tethered MT1-MMP and the soluble
MMP-2 with the fibrous ECM phase, in this work we investigate the MT1-MMP/MMP-2
cascade and its overall effect on tumour progression. To that end, we will
propose a new multiscale modelling framework by considering the degradation of
the ECM fibres not only to take place at macro-scale in the bulk of the tumour
but also explicitly in the micro-scale neighbourhood of the tumour interface as
a consequence of the interactions with molecular fluxes of MDEs that exercise
their spatial dynamics at the invasive edge of the tumour
- …